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Abstract: Chronic colonic inflammation, as well as exposure to psychological stressors, are well 
known risk factors for the development of colorectal cancer. Whether these two predisposing 
factors are linked, however, is not known. A murine social stressor, called social disruption 
(SDR), was used to test whether stressor exposure would increase colonic inflammation in mice 
infected with the colonic pathogen Citrobacter rodentium. When compared to non-stressed 
control mice infected with C. rodentium, stressor-exposure significantly increased pathogen-
induced colonic histopathology, inflammatory cytokine gene expression, and the accumulation of 
F4/80
+
 macrophages in the colon. Other studies demonstrate that exposure to the SDR stressor 
without infection significantly increases the number of inflammatory monocytes in the spleen. 
Because splenic inflammatory monocytes can traffic to sites of inflammation, the goal of this 
study was to determine whether these accumulated colonic F4/80+ macrophages display an 
inflammatory phenotype (i.e., L6C
hi
CCR2
+
CD11b
+
) by using flow cytometry. To test whether 
colonic inflammation could be significantly enhanced by colonic macrophages, an adoptive 
transfer model was also used. In this experiment, monocytes isolated from the spleens of stressed 
mice were introduced into naïve mice, which were later infected with C. rodentium. It is 
expected that these non-stressed recipient mice will display similar inflammation and pathology 
as stressed mice. If proven true, it would mean that the stressor-primed splenic inflammatory 
monocytes are responsible for enhanced colonic inflammation. Increases in colonic macrophages 
may account for stressor-induced increases in colonic inflammation. Future studies will test the 
hypothesis that this increased inflammation predisposes animals to developing colorectal cancer. 
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1. Introduction 
 Psychological stress has been shown to have profound effects on physiological functions, 
especially in disease pathology (Bartolomucci et al., 2007). Importantly, among the different 
functions that are affected is the immune system. Stress can have a complex effect on the 
immune system, in some situations enhancing it, and others depressing it; however in most cases 
the effects are deleterious. Many of these negative effects are due to enhancement of the 
inflammatory immune response, which can lead to chronic and pathological inflammation. 
Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease are 
particularly sensitive to stress, being linked to causing new flare-ups. Furthermore, chronic 
inflammation and stress have been implicated in increased risk for developing cancer, especially 
in the colon.  
   
 1.1  Psychological Stress: 
 Psychological stress can be defined as an organism’s physiological and behavioral 
response to a perceived potential danger. Stress alters and modulates many of the body’s normal 
functions in order to prepare the organism to cope with the potential danger, through a “fight or 
flight” response. When an organism encounters a stressor, two major pathways are activated 
which bring about these modulations (Bartolomucci, 2007). One of these pathways involves the 
activation of the hypothalamic-pituitary-adrenal (HPA) axis and the release of glucocorticoids 
(Leonard et al., 2005). Glucocorticoids (cortisol in humans, corticosterone in mice) stimulate an 
increase in gluconeogenesis to ensure high glucose availability for ready use in quick bursts of 
energy (Khani et al., 2001). Additionally, glucocorticoids generally have immunosuppressive 
activity and are effective in reducing inflammation (Coutinho, 2011). The second major system 
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is the sympathetic nervous system (SNS), which innervates almost every organ in the body and is 
responsible for the well known “fight or flight” response (Bartolomucci, 2007). Activation of the 
SNS results in the almost immediate release of catecholamines such as epinephrine and 
norepinephrine (Carrasco et al., 2003). Catecholamines have many immunomodulatory 
behaviors, mainly regulatory and suppressive roles, such as decreasing TNF-α production by 
macrophages (Nance et al., 2007). 
 
 1.2  Stress Effect on the Immune System: 
 There is a widely acknowledged intimate relationship between stress and the immune 
system (Bartolomucci, 2007), (Pruett et al., 2003), (Segerstrom et al., 2004). The relationship is 
bi-directional: stress is capable of modulating the immune system, and the immune system is 
capable of inducing a stress response. Generally, stress is known to suppress the immune system. 
The release of glucocorticoids has strong immunosuppressive and anti-inflammatory effects, and 
they are known to inhibit the activity of lymphocytes and macrophages (Da Silva et al., 1999), 
(Reiche, 2004). However in many cases, stress has been shown to enhance the immune response, 
especially in inflammatory and autoimmune diseases (Dhabhar et al., 2002), in part by causing a 
redistribution of immune cells throughout tissues and the blood (Dhabhar et al., 2012).  
 Social stress in particular is a well defined and effective laboratory stressor 
(Bartolomucci, 2007). Venzala et al. examined the comparability of murine social stressors as 
models for human psychological disorders. They found that their stressor models significantly 
increased anxiety-like and other abnormal behavior over a range of behavior tests. Although they 
concluded social stressors are not perfect models for clinical depression, they acknowledged that 
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they accurately model many of the symptoms and behaviors of depression and anxiety-related 
disorders (Venzala et al., 2012).  
 Social disruption (SDR) is a well defined social stressor in which subordinate young mice 
are attacked and defeated by an older aggressive mouse over a span of 2 hours for 6 consecutive 
days. Defeated mice have been shown to have elevated levels of systemic corticosterone as well 
as modulated behavior (Avitsur et al., 2001). The SNS is also activated during SDR, as are brain 
regions associated with the activation of the SNS. Importantly, it has been reported that SDR can 
increase CD11b
+
 myeloid-derived leukocytes, such as neutrophils and monocytes both in 
circulation and in the spleen (Engler et al., 2004). Furthermore, splenocytes isolated from these 
stressed mice have been shown to have a decreased sensitivity to glucocorticoid inhibition in 
addition to expressing higher levels of inflammatory cytokines upon antigen stimulation (Bailey 
et al., 2003). 
 
 1.3 Inflammation   
 Inflammation is marked by the release of cytokines that stimulate the symptoms that are 
associated with the inflammatory response. Two well known markers are TNF-α and IL-1. TNF-
α is important in basic immunity against pathogens including bacterial, viral and parasitic 
infections. TNF-α is produced primarily by activated macrophages and T cells. It precipitates the 
activation of complex and numerous pathways that culminate in the activation of NF-κB, a 
transcription factor pathway which has been shown to be pivotal in 221 other molecular 
associations (Bouwmeester et al., 2004). TNF-α stimulates the production of different selectins 
on vascular endothelial cells as well as vasodilatation, both of which are essential for recruiting 
leukocytes out of circulation and into the tissue. TNF-inhibiting drugs effectively treat a wide 
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range of chronic inflammatory diseases (Vincent et al., 2012) including Crohn’s disease 
(Hanauer et al., 2002). TNF antibodies can also prevent septic shock when injected with a lethal 
dose of bacteria (Tracey et al., 1987).  
 There are two forms of interleukin-1, IL-1α and IL-1β, that play important roles in the 
inflammatory response and inducing the expression of many other inflammatory genes 
(Dinarello et al., 2009). Exposure to the SDR stressor has been shown to lead to increases in both 
TNF-α and IL-1 upon stimulation (Engler et al., 2004). 
 Chemokines are a subclass of cytokines known for their role in leukocyte chemotaxis and 
homing. Chemokines are produced by cells at the site of infection, and incoming leukocytes 
travel up the concentration gradient towards the site. They can also be used to concentrate 
immune cells in specific locations, such as lymphoid tissue (Bachmann et al., 2006). CCL2 is an 
important inflammatory cytokine. It can be secreted by a range of cells including monocytes, 
macrophages, T cells, fibroblasts, endothelial cells, and mast cells. The cell receptor for CCL2 is 
CCR2, and is commonly found on proinflammatory cells such as infiltrating monocytes (Shachar 
et al., 2013).  CCR2 is essential for monocyte recruitment and K/O mice exhibit significantly 
reduced numbers of leukocytes in tissue (Kuziel et al., 1997). 
 Inflammation in the colon is of particular interest because of its association with 
inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease, and its 
predisposal for developing colorectal cancer (CRC). Furthermore, colonic inflammation has 
strong correlations with stress.  
 The lumen of the colon is home to approximately ten times more bacterial cells than there 
are human cells in the body. These bacteria are commonly referred to as the colonic microbiota 
and have been shown to have numerous beneficial effects for the host. The epithelium of the 
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colon provides a physical barrier to contain the bacteria both through tight junctions and the 
production of a mucosal layer. The lamina propria, which lies directly beneath the epithelial 
layer, contains a wide variety of immune cells including macrophages, neutrophils, dendritic 
cells, natural killer T cells, and T and B cells. There is an intricate balance between these 
immune cells and the microbiota. The immune cells must be prevented from activating against 
all the normal microbiota, but also must be able to recognize and attack pathogens. Dysfunction 
of this balance can lead to chronic inflammation in the colon, which can lead to pain, discomfort, 
tissue pathology, and potentially the removal of the colon or development of CRC (Abraham et 
al., 2009). One type of cell that is involved with chronic inflammation in the colon it the 
macrophage. 
 
 1.4 Macrophages 
 Macrophages are generally tissue associated leukocytes of the innate immune response. 
They are mononuclear phagocytes, and play a vital role in orchestrating the initial immune and 
inflammatory responses. Monocytes are myeloid-derived cells in the blood stream, which 
differentiate into macrophages upon leaving the blood and entering the tissue. 
 Both monocytes and macrophages are highly heterogenous, and display a wide range of 
phenotypes based on their tissue location and function (Gordon and Taylor, 2005). Different 
macrophage phenotypes can have diverse and contradictory behaviors including phagocytic, 
inflammation-promoting, inflammation suppressing, cancer-promoting, cancer-suppressing or 
wound healing. F4/80 is a cell surface marker that is especially prevalent and highly expressed 
on macrophages in tissue, but lower levels can be found on dendritic cells and activated 
eosinphils. It is commonly used as a marker for macrophages in the lamina propria, where it is 
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highly expressed (Gordon et al., 2011). Important for the colon are inflammatory and anti-
inflammatory macrophages, often roughly referred to as M1 and M2, respectively. The M2 
phenotype is associated with wound healing, tissue restructuring and anti-inflammatory behavior. 
Arginase, an enzyme which competitively inhibits iNOS activity, and TGF-β production are 
associated with M2 phenotypes (Martinez et al., 2008). The M1 phenotype is associated with 
inflammation and marked by TNF-α, iNOS and CCL2 production. TNF-α plays a crucial role in 
recruiting monocytes/macrophages to sites of infection, inflammation and tissue damage, as well 
as organizing cellular structure (Locksley et al., 2001). Although TNF-α can have anti-tumor 
properties, over-expression can lead to cancer through a number of pathways, including growth 
and angiogenic factors, cellular restructuring, and most importantly for this study, through 
inflammation, recruitment of macrophages and stimulation of iNOS (Szlosarek et al., 2001). The 
enzyme iNOS is expressed by inflammatory macrophages and leads to the synthesis of nitric 
oxide (NO). NO and its byproducts can undergo a number of disruptive reactions with DNA, 
many leading to cell death, but some leading to genetic mutations (Ambs, et al., 1998). Tumors 
are associated with high levels of iNOS, and inhibition of iNOS has been shown to significantly 
decrease adenocarcinoma development in the pancreas of hamsters (Takahashi et al., 2008), as 
well as in an azoxymethane-induced model for CRC in rats (Takahashi et al., 2006). 
 
 1.5 Citrobacter rodentium 
 Citrobacter rodentium is a noninvasive murine pathogen which colonizes the epithelium 
of the colon and induces disease pathology similar to enteropathogenic Escherichia coli (EPEC) 
in humans. Previously classified as Citrobacter freundii biotype 4280, C. rodentium strains were 
shown to contain genes identical to eaeA and eaeB in E. coli, which are necessary for the 
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characteristic attaching and effacing lesions associated with EPEC infections (Schauer et al., 
1995). Oral infections with C. rodentium result in a well defined disease known as transmissible 
colonic hyperplasia which is characterized by thickening of the mucosal layer, epithelial cell 
proliferation, goblet cell depletion and elongation of intestinal crypts (Bhinder et al., 2013), 
(Higgins et al., 1999).  
 Importantly, infections with C. rodentium have been shown to be effective models for 
inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease (Higgins et al., 
1999). Higgins et al. demonstrated that the immune response to C. rodentium was marked by 
high percentages of CD4
+
 T-cells, increased IL-12, and TNF-α; all of which indicate a Th1 
response. They also noted that the infiltration patterns of the T-cells and macrophages bore 
strong resemblance to the patterns seen in the chronic inflammation of IBDs.  
 
 1.6 Cancer 
 The intricate relationship between stress, the immune system and inflammation have 
important implications for cancer growth and development. Understanding these relationships is 
vital for forming an effective cancer prevention and treatment regimen.  
 Psychological stress and other behavioral factors have been shown to play an important 
role in cancer development and progression (Lutgendorf and Sood, 2011), (Costanzo et al., 
2011). Stress has been linked to shorter survival in breast cancer patients (Giese-Davis and 
Spiegel, 2003). Exposing laboratory mice to experimental psychological stressors has been used 
to model these effects in humans, and in a murine breast cancer model, exposure to stress 
increased cancer metastasis by 30-fold. This effect was found to be due to stress induced 
activation of the sympathetic nervous system (Sloan et al., 2010). These effects, however, are not 
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limited to breast cancer. Stressed mice have also been shown to develop skin cancer significantly 
quicker than non-stress mice in an ultraviolet light-induced squamous cell carcinoma model 
(Saul et al., 2005). The mechanisms by which exposure to psychological stressors can enhance 
cancer progression are not well defined, but could involve stressor-induced increases in 
inflammatory responses.  
 Several studies have demonstrated a key relationship between chronic inflammation and 
cancer growth and development (Colotta et al., 2009). This effect is likely bidirectional. 
Inflammatory genes have been shown to be induced by oncogenes. For example, in an in vitro 
thyroid cancer cell model, the RET/PTC1 oncogene induces the expression of inflammatory 
genes, such as the gene encoding for CCL2 (Borrello et al., 2005 ). CCL2 recruits inflammatory 
monocytes, as well as activated T cells, to sites of inflammation where they produce 
inflammatory cytokines, like TNF-α and IL-1β, as well as reactive oxygen and nitrogen 
intermediates (Daly et al., 2003). These inflammatory cytokines and reactive intermediates have 
been shown to promote tumorigenesis through induction of a pathway that inhibits DNA 
mismatch repair enzymes and increases angiogenic factors (Jung et al., 2004) (Koshiji et al., 
2005). While the cancer-inflammation relationship is important for all cancer types, it is 
especially apparent in colorectal cancer. Diseases marked by chronic colonic inflammation, such 
as inflammatory bowel diseases (IBD), have been shown to greatly increase the likelihood of 
developing colorectal cancer (CRC) (Jawad et al., 2011). It is estimated that only 20% of CRC 
cases are associated with hereditary causes (Rustgi, 2007), while the remaining portions are 
induced by environmental factors, and overwhelmingly those which induce inflammation and 
colitis (Terzic, et al., 2010). A collation of data from 19 articles suggests that 30 years after 
diagnosis with IBD, an average of 1 in 5 cases will result in CRC diagnosis, and about 50% of 
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those cases result in death (Lakatos et al., 2008). Importantly, the general risk of developing 
CRC can be significantly reduced through regular use of anti-inflammatory drugs such as aspirin 
(Chan et al., 2007). Thus, it is evident that colonic inflammation significantly increases CRC 
progression. 
 M1 macrophages create an inflammatory environment ideal for tumor formation as 
previously described, while M2 is the phenotype expressed by tumor-associated macrophages 
(TAM) (42). Tumors have been shown to produce CCL2, a chemotactic cytokine for CCR2+ 
inflammatory macrophages (Sica et al., 2008). Thus, stressor-induced increases in colonic 
macrophages, particularly during chronic colonic inflammation, could result in an internal 
environment conducive to the formation of colorectal cancer. 
 
Purpose: The purpose of this thesis was to characterize macrophages in the colon during 
stressor-enhanced pathogen-induced inflammation, and to test the hypothesis that cytokines 
associated with M1 macrophages will be increased in stressor-exposed mice. Another goal of this 
thesis examine if social stress and colonic inflammation increases susceptibility to developing 
CRC.  
 
3. Methods and Materials 
 3.1 Mice and Social Disruption 
 Wild type, male C57BL/6 mice, aged 6-8 weeks, were purchased from Charles River 
Laboratories (Wilmington, MA) and housed 3 per cage in an AAALAC-approved facility. Mice 
were kept on a 12 hr light:dark schedule with lights on at 0600 hrs and given food and water ad 
libitum. After arrival, mice were given one week for acclimation, and observed for any sign of 
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inter-cage aggression. Social disruption involves introducing an aggressive male mouse into the 
cage of the SDR mice for two hours per evening, from 1700 to 1900 hrs, for six consecutive 
evenings. During this time, the aggressive male attacks and repeatedly defeats the young mice. 
SDR cages were observed for 20 min at the beginning of each cycle to ensure adequate fighting. 
Control mice were left undisturbed, and monitored for inter-cage fighting. After the first cycle of 
SDR, all mice were infected via oral gavages with 100 μl of Citrobacter rodentium strain 
DBS120 (pCRP1::Tn5) in PBS at a concentration of about 1-3 x 10
7 
CFU/ml. Mice were 
sacrificed on days 0, 6, 12, and 24 post-infection by CO2 inhalation. Colons and spleens were 
removed and weighed, and snap-frozen in liquid nitrogen. 
 On days 1, 3, 6, 12, and 24 post-infection, stool was collected and cultured to determine 
extent of C. rodentium infection. Stool was homogenized and serially diluted in PBS. The C. 
rodentium used had a kanamycin resistance cassette, and therefore aliquots of the homogenized 
stool were plated on Lactose MacConkey agar (Becton Dickinson) supplemented with 
kanamycin (40 μg/ml) to select for the pathogen. Plates were incubated at 37 °C overnight 
without CO2, and the number of colony forming units (CFU) per gram of fecal matter 
determined.  
 3.2 Measurement of gene expression by Semi-Quantitative Real Time PCR Analysis 
 On days 0, 6, 12, and 24 post-infection, colons were harvested and total RNA was 
extracted using Trizol reagent as per manufacturer’s protocol (Invitrogen, Carlsbad, CA). After 
isolation, total RNA was spectrophotometrically quantified so that a reverse transcription 
reaction of 2 μg of RNA could be performed to synthesize cDNA. The reverse transcription 
reaction makes a DNA copy (cDNA) of an RNA molecule, using the Avian Myeloblastosis 
Virus (AMV) Reverse Transcriptase enzyme (Promega Corporation, Madison, WI).  These 
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samples then underwent Real-time Polymerase Chain Reaction (PCR), in order to amplify the 
nucleotide sequences of interest, which included mRNA for TNF-α, iNOS, CCL2, arginase, and 
TGF-β. The housekeeping gene that was used was 18S. Primers and probes were synthesized by 
Applied Biosystems.  
 The PCR mixture consisted of 2.5 μl of cDNA, 2.5 μl of primer mix, 2.5 μl of probe (or 
SYBR Green for arginase and TGF-β), 5 μl of sterile H2O, and 12.5 μl of Tagman Universal 
Master Mix (PE Applied Biosystems, Foster City, CA) for a final volume of 25 μl. After an 
initial 2-min cycle at 50ºC followed by 10 min at 95ºC, the reaction ran for 40 total cycles, which 
consisted of a 15-s denaturing phase (90ºC) and a 1 min annealing/extension phase at 60ºC. The 
change in fluorescence was measured using an Applied Biosystems 7000 Prism Sequence 
Detector (PE Applied Biosystems) and analyzed using Sequence Detector version 1.0. The 
relative amount of transcript was determined using the comparative cycle threshold (Ct) method 
as described by the manufacturer.  
 3.3 Quantification of F4/80+ cells in colon tissue 
 Colons were harvested from SDR and HCC mice on days 0, 3, 6, 12, and 24 post 
infection and fixed in 10% formalin. Samples were then sent to the Vet Core where they were 
embedded in paraffin and sliced. The tissue was counterstained and treated with F4/80 primary 
antibody, and then a secondary antibody conjugated with horse radish peroxidase for 
visualization. The samples were photographed under a microscope at 100X. Every 5
th
 
photograph was quantified using Photoshop, as described previously (Eubank et al., 2009). In 
Photoshop, a positive pixel coloring was identified. The histogram was then run which turned all 
positive pixels black, and the rest of the pixels white. The percentage of pixels that were black 
was then determined. Pictures were cropped so that percentages reflected only colon tissue. 
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 3.4 Lamina Propial Lymphocyte Isolation and Flow Cytometry 
 Colons were harvested from SDR and HCC mice on day 12 post infection and flushed 
with HBSS. Excess fat tissue was removed from the colon, bisected, and then cut into 0.5 cm 
pieces which were placed in 1 mM dithioerythritol in HBSS solution. Samples were then shaken 
at 37 ºC for 30 min, the supernatant removed, the tissue resuspended in 5% FBS in RPMI and 
collagenase (4.975 mg/25ml) solution, and shaken at 37ºC for an additional 90 min. Supernatant 
was then filtered with a 70 μl cell strainer, washed, counted, and resuspended for flow staining. 
Fifty thousand cells were stained with 1 μl of FITC labeled CD45, PerCP labeled F4/80, and 
APC labeled CD11b in panel one and CD45-FITC, CCR2-PE, and CD11b-APC in panel two. 
Two panels for lymphocytes were also used, with antibodies for CD45-FITC, CD3-PE, CD4-
PerCP and CD8-APC. CD45 is a marker used to identify leukocytes in general. CD3 is a marker 
used to identify T cells, CD4 and CD8 are markers for helper and cytotoxic T cells. Expression 
of these cell markers was determined on a Becton-Dickinson FACSCaliber four color cytometer, 
and 10,000 events were recorded. Flow results were gated first for mononuclear cells via forward 
and side scatter, then CD45+ cells, then CD11b+ cells, then CCR2+CD11b+ cells. A gate was 
set on CD45+ cells to determine the percentage of mononuclear cells that were CD45
+
. Within 
the CD45
+ 
cells, a gate was set to determine the percentage of CD45
+
 cells that were CD11b
+
, 
and what percentage of cells were both CD11b
+ 
and CCR2
+
. 
 3.5 AOM Study 
 In a second study, mice subjected to SDR in combination with azoxymethane (AOM) to 
assess colonic tumor formation. One week after arrival, the mice were given an inter-peritoneal 
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(IP) injection of 100 μl of either AOM at a concentration 1 mg AOM per 1 kg of body weight, or 
PBS. The first cycle of SDR was started one week after IP injections and C. rodentium was 
gavaged afterwards. Five more cycles of SDR were performed, and then the mice were left 
undisturbed until 20 weeks post-IP injection. Body masses were measured every other week, 
starting on week 8.  At week 20, mice were euthanized by CO2 inhalation. Livers, spleens, and 
colons were removed and weighed, colon length was measured, and tissues were snap-frozen in 
liquid nitrogen. Before freezing, colons were examined for signs of tumors, contents were 
removed, and the tissue was bisected longitudinally into two equal pieces. Half was frozen for 
storage, and half was fixed in 10% formalin for hematoxylin and eosin (H&E) staining, and 
histopathology analysis.   
 3.6 Statistical Analysis  
 To determine the differences between SDR stressor mice and HCC control mice, two-
factor analysis of variance (ANOVA) with group (i.e., HCC vs. SDR) and day (i.e., 0, 6, 12, and 
24) as between subject variables. For studies involving AOM, a third factor was added (i.e. 
AOM vs. PBS). The level of statistical analysis was set at p<.05. SPSS for Windows version 19 
(SPSS, Chicago, IL) was used for all analyses.  
4. Results 
 4.1  Macrophage Characterization 
 The data indicates that SDR increased the number of C. rodentium could be colonized 
from the stool, with the infection peaking on day 12. The SDR group had a marginally 
significant increase in C. rodentium across the 24 day period (F(1,64)=3.577, p=.064), highest on 
day 12 post-challenge. Non-stressed HCC mice tended to show little or undetectable amounts of 
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C. rodentium (figure 1). The detectable range for this experiment was from log(10) 2.6 to log(10) 
7.2 CFU/gram of fecal matter.  
 Figure 2 shows tissue samples after staining with F4/80 antibody. Positive cells shown on 
the left are visualized by a secondary antibody conjugated to horse radish peroxidase, which 
turns brown. Photoshop was used to convert positive brown cell pixels to black, and all other 
pixels to white.  The percentage of black pixels in the area of the tissue was then determined 
using Photoshop. SDR significantly increased the percentage of F4/80
+
 pixels in colon tissue 
over HCC over the course of the infection (F(4,26)=3.12, p<.05). Post-hoc testing indicated this 
was due to a significant increase on day 12 post-infection.  
 Figure 3 shows the results for real time PCR performed on colon tissue from stressed and 
non-stressed mice. Figures 3A and 3B show genes associated with M2 phenotypes, namely 
arginase and TGF-β. Although the mean level of TGF-β mRNA was lower in mice exposed to 
SDR compared to control mice, this difference did not reach statistical significance 
(F(1,16=0.16, not significant). Stressor exposure did not effect arginase mRNA levels (F(1,16)-
0.59, not significant). However, as shown in graphs C, D, and E, expression levels of genes 
associated with M1 phenotypes appear to change with stress. TNF-α expression was found to be 
significantly increased in SDR over HCC across days (F(3,24)=3.172, p<.05) with significant 
differences occurring on day 6 post-infection. Expression of iNOS also significantly increases 
with stress across days (F(3,24)=3.529, p<.05) with SDR being higher than HCC on days 6, 12, 
and 24 post-challenge.  However, CCL2 was not found to be significantly changed 
(F(3,24)=9.337, not significant). 
 Figure 4 shows the results of flow cytometry performed on the leukocytes isolated from 
the lamina propria of the colon. As seen in figures 4A and 4B, there are more CCR2
+
CD11b
+
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events in SDR mice than in HCC mice. Figure 4C shows that stress induces a marginally 
significant increase in CD11b
+ 
cells (t(7)=2.23, p=.06) and a marginally significant increase in 
double positive CCR2
+
CD11b
+
 cells (t(6)=2.16, p=.07). There was not a significant change in 
either CD4
+ 
cells (t(4)=0.23) or in CD8
+
 cells (t(4)=0.95).  
 4.2 Azoxymethane Study 
 
 Figure 5 shows the levels of C. rodentium that were cultured from stool. The groups 
which received SDR, PCS (non-AOM PBS injection, C. rodentium infection, SDR) and ACS 
(AOM injection, C. rodentium infection, SDR) had a significantly increased colonization over 
the non-stressed groups, ACH (AOM injection, C. rodentium, HCC) and PCH (non-AOM PBS 
injection, C. rodentium infection, HCC) (F(3,64)=4.37, p<.05) across days with highest 
colonization occurring on day 12. The PBS mice also had significantly higher colonization over 
the AOM mice (F(1,64)=11.66, p<.001) 
 Masses of spleen, liver, and colon were measured. There appeared to be no significant 
trend between any of the variables. The same seemed to be true for the length of the colon.  
 Table 2 shows histopathology scores assigned to colon tissue harvested from week 20 
post-inejection. Tissues were assessed by a blinded pathologist for the listed inflammation 
pathology and given a score between 0 and 4, where 0 is healthy tissue and 4 is the most severe. 
There were no signs of continued inflammation in any of the samples, or indicators of tumors or 
pre-tumors.  
 
5. Discussion 
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 A previous study demonstrated that mice exposed to the SDR stressor during oral 
challenge with C. rodentium shed higher levels of C. rodentium into the stool and an increase in 
C. rodentium-induced pathology (Galley et al., In Preparation).  One measure in the pathogen 
colitis index is the accumulation of leukocytes in the colonic tissue, however, previously it was 
not known which types of leukocytes accumulate in the colon.  The current study used 
immunohistochemistry for F4/80, to demonstrate that F4/80
+ 
cells increase with SDR and C. 
rodentium infection. Since F4/80 is generally a marker for macrophages, it is likely that it is 
F4/80
+
 macrophages that are increasing with stress.  However, dendritic cells (DC) can also 
display an F4/80
+ 
phenotype, so it is possible that cells in addition to macrophages increase in the 
colon during stressor exposure.  
 Working with the hypothesis that macrophages are increasing with stress, we sought to 
further characterize the macrophages. Since macrophages can be either pro-inflammatory M1 
type or anti-inflammatory M2 type, we performed real time PCR on colon tissue from day 12 
mice. We looked for gene expression associated with the two different phenotypes. Expression 
of TNF-α, and inducible nitric oxide synthase (iNOS), genes associated with M1 macrophages 
were increased, while arginase and TGF-β expression, genes associated with M2 macrophages, 
had no significant change. Although these cytokines can be made by other cell types they have 
been used as markers for characterization (Martinez, et al.  2008). Thus, it seems reasonable that 
the macrophage population increased in the colon is of the M1 phenotype.  
 To further characterize the colonic macrophage population, flow cytometry was 
performed on lymphocytes isolated from the lamina propria of the colon. It was shown that of 
CD45
+
 cells (a marker for leukocytes), stress increased both CD11b
+
 cells and double positive 
CCR2
+
CD11b
+ 
cells. Other studies have also demonstrated increased populations of 
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CCR2
+
CD11b
+ 
cells present in the colon during inflammation, and have found these cells to be 
cytokine producers (Bain, 2012)  Flow analysis also revealed that CD4
+ 
and CD8
+ 
cells remained 
unchanged between stressed and unstressed animals, suggesting that increased T-cell numbers 
are not associated with stressor-enhanced inflammation.  
 Even though inflammatory macrophages and monocytes can be protective against 
bacterial infection (Fujiwara and Kobayashi, 2005), they can also contribute to uncontrolled 
colonic inflammation (Platt et al., 2010). Platt et al. demonstrated that they could isolate two 
distinct macrophage populations in the gut, F4/80
+
TLR2
-
CCR2
-
CX3CR1
hi
 macrophages, which 
appear to be M2 type, and F4/80
+
TLR2
+
CCR2
+
CX3CR1
int
 macrophages, which appear to be M1 
type. They isolated the M2 type macrophages from resting colons, and found that they produced 
little to no TNF-α upon LPS stimulation. They isolated M1 type macrophages from colons 
during experimental colitis, and found that they produced high levels of TNF-α upon stimulation. 
They also showed that CCR2 knockout mice showed reduced M1 type macrophages, and also 
reduced levels of colitis, suggesting that these macrophages are contributing to the inflammation. 
 Conversely, Hunter et al. have shown that a tape worm Hymenolepis dimunuta, which has the 
ability to alternately activate macrophages, can reduce colitis in a DSS model. These alternately 
activated macrophages have increased expression levels of arginase and appear to be of the M2 
phenotype, although further characterization was not performed (Hunter et al., 2010). 
 Chronic inflammation is a well known predisposing factor for developing cancer 
(Coussens and Werb, 2002) (Perwez-Hussain and Harris, 2007), especially in the colon (Jawad et 
al., 2011), because the inflammation creates an environment ideal for carcinogenesis. Enzymes 
such as iNOS produce free radicals which can induce mutations in host DNA. Inflammation is 
also often marked by an increase in growth factors, nutrients, and blood supply, all of which are 
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vital for the proliferation of cancer cells. Furthermore, colonic inflammation is often marked by 
rapid epithelial cell proliferation, a process which if mutated to become constitutive, could easily 
lead to tumor formation. 
 Stressor exposure increases C. rodentium induced pathology at the peak of infection 
(Galley et al., In Preparation). In this study, we did not find evidence that the increased 
inflammation increased susceptibility to development of CRC. In fact, tumors or pre-tumor 
histological activity was not found in any animal in this study. It is important to note however, 
that the chronicity of inflammation is an important factor for CRC development. In our model, 
we know that stressor-enhanced colonic inflammation peaks around day 12 post-pathogen, and 
that both infection and inflammation is essentially resolved by day 24 post-infection (Galley et 
al., Unpublished Observation). Thus, it is possible that a more prolonged inflammatory response 
would be more likely to induce CRC development. 
 However, this study was based off of studies by Suzuki et al., which used dextran sodium 
sulfate (DSS) as the mode for inducing colonic inflammation. Suzuki’s lab demonstrated that 
CRC could be induced with a single injection of AOM followed a week later by a week of DSS 
administration, whereas previous labs used multiple weekly injections of AOM (Suzuki et al., 
2003).  Our study simply replaced the DSS step with C. rodentium infection and SDR. DSS 
induces a similar, albeit more severe, inflammatory response in the colon, and resolves itself in a 
similar time frame (Yan et al., 2009). Since the inflammation induced by DSS lasts for a similar 
time frame to our lab’s model, it seems less likely that a short duration of inflammation was the 
responsible for a lack of tumor formation. It is also possible that Suzuki’s model is effective 
because DSS induces a more severe and disruptive colitis than our model. 
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Furthermore, our results show that mice that received a PBS IP injection had significantly higher 
C. rodentium colonizations over mice that received AOM. Thus, it is possible that AOM could 
have either interfered with C. rodentium colonization, or killed C. rodentium directly directly, 
leading to even less severe colitis.  
 Since CRC can be induced with AOM injections alone, it is possible that SDR still might 
increase susceptibility for CRC if more than one AOM injection was administered. It is also 
possible that a different form of stressor used by this lab, namely prolonged restraint, could also 
prove more successful, due to the more severe colitis it illicits.  
 
Conclusion: 
 This study demonstrated that F4/80
+ 
cells increase in the colon with social stress and 
pathogen challenge and that these macrophages are likely of the M1 phenotype. Gene expression 
levels that are associated with and are used to mark M1 macrophages are increased in stressed 
mice over non-stressed mice. Furthermore, flow analysis showed that these cells had markers 
commonly accepted as markers of inflammatory macrophages. Additional studies are needed to 
further confirm these results. 
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Figure Legends 
Figure 1: C. rodentium colonization during SDR.  Fecal sheddings were collected on days 1, 3, 
6, 12, and 24 post-infection, homogenized and plated on Lactose Mackoney agar supplemented 
with kanamycin (40 μg/ml) at 37ºC for 24 hrs. These data points represent the log(10) colony of 
forming units (CFU) per gram of fecal matter +/- standard error mean (SEM). The SDR group 
had a marginally significant increase in C. rodentium across the 24 day period (F(1,64)=3.577, 
p=.064), highest on day 12 post-challenge. n=6 
Figure 2: F4/80
+
 staining of colonic tissue during SDR. Colon tissue was harvested from SDR 
and HCC mice on days 0, 3, 6, 12, and 24 post-challenge with C. rodentium, fixed in 10% 
formalin, embedded in paraffin. Figure 2A and 2C represent colon tissue stained with F4/80 
primary antibodies and visualized with horse radish peroxidase secondary antibodies. F4/80
+
 
cells are seen as brown. Samples were photographed at 100X and quantified using Photoshop. 
Positive pixels were turned black and negative white with a histogram in order to determine 
percentage of positive pixels, as shown in Figures 2B and 2C. Data points in Figure 2E represent 
mean F4/80
+
 pixel percentage +/- SEM. SDR significantly increased the percentage of F4/80
+
 
pixels in colon tissue over HCC over the course of the infection (F(4,26)=3.12, p<.05). Post-hoc 
testing indicated this was due to a significant increase on day 12 post-infection. Day 12, n=6, day 
0, 3, 6, 24 n=3 
Figure 3: Real Time PCR of mRNA isolated from colonic tissue during SDR. Colon tissue 
was harvest from mice on days 0, 6, 12, and 24 post-challenge with C. rodentium, mRNA was 
isolated using Trizol, and cDNA was synthesized. Real time PCR was run using mRNA primers 
for TGF-β, ARG-1, TNF-α, iNOS, and CCL2. Data points on Figures 3A-3E represent mean n-
fold increase of expression over control mice minus expression of housekeeping gene 18S +/- 
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SEM. Figure 3A shows the mean level of TGF-β mRNA was lower in mice exposed to SDR 
compared to control mice, but was not statistical significance (F(1,16=0.16, not significant). 
Figure 3B shows stressor exposure did not effect arginase mRNA levels (F(1,16)-0.59, not 
significant). In Figure 3C shows TNF-α significantly increased in SDR over HCC group across 
days (F(3,24)=3.172, p<.05) with significant differences occurring on day 6 post-infection. 
Figure 2D shows expression of iNOS also significantly increases with stress across days 
(F(3,24)=3.529, p<.05) with SDR being higher than HCC on days 6, 12, and 24 post-challenge.  
Figure 2E shows CCL2 did not significantly change (F(3,24)=9.337, not significant). n=3 
Figure 4: Flow cytometry of day 12 colon tissue. Colons from mice subjected to SDR and 
HCC were harvested; lamina proprial lymphocytes were isolated and stained with stained with 
CD45-FITC, F4/80-PerCP, and CD11b-APC in panel one and CD45-FITC, CCR2-PE, and 
CD11b-APC in panel two. Two panels for lymphocytes were also used, with antibodies for 
CD45-FITC, CD3-PE, CD4-PerCP and CD8-APC. Figures 4A and 4B show that there are more 
CCR2
+
CD11b
+
 events in SDR mice than in HCC mice. Figure 4C shows that SDR mice had a 
marginally significant increase in CD11b
+ 
cells (t(7)=2.23, p=.06) and 4D shows a marginally 
significant increase in double positive CCR2
+
CD11b
+
 cells (t(6)=2.16, p=.07). Figures 4E and 4F 
show there was not a significant change in either CD4
+ 
cells (t(4)=0.23) or in CD8
+
 cells 
(t(4)=0.95). n=3  
Figure 5: Figure 1: C. rodentium colonization during SDR and AOM.  Fecal sheddings were 
collected on days 1, 3, 6, 12, and 24 post-infection, homogenized and plated on Lactose 
Mackoney agar supplemented with kanamycin (40 μg/ml) at 37ºC for 24 hrs. These data points 
represent the log(10) colony of forming units (CFU) per gram of fecal matter +/- SEM. The 
groups which received SDR, and ACS  had a significantly increased colonization over the non-
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stressed groups, ACH and PCH (F(3,64)=4.37, p<.05) across days with highest colonization 
occurring on day 12. The PBS mice also had significantly higher colonization over the AOM 
mice (F(1,64)=11.66, p<.001). n=6  
Figure 7: Organ masses and lengths at 20 weeks post-injection. Mice were euthanized and 
their livers, spleens, and colons were removed and weighed. Colon length was measured. There 
were no statistically significant differences in group for spleen mass (F(1,40)=.446) not 
significant), liver mass (F(1,40)=3.895), colon mass (F(1,45)=0.04), or colon length 
(F(1,40)=1.622). n=6  
Table 1: Pathology Assessment of AOM Colon Tissue. Colon tissue was harvest from mice 20 
weeks post-injection, fixed in formalin, embedded in paraffin, stained with H&E, and scored by 
a pathologist based on a scale of 0 to 4, 0 being healthy. No changes were observed. 
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Figure 3 
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Figure 4
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AOM group: 
C.rodentium + SDR (ACS) Vehicle + SDR (AVS) 
C.rodentium + HCC (ACH) Vehicle + HCC (AHS) 
 
PBS group: 
C.rodentium + SDR (PCS) Vehicle + SDR (PVS) 
C.rodentium + SDR (PCH) Vehicle + HCC (PHS) 
 
Figure 5 
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Figure 6 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Inflamm Edema Epithelial 
defects 
Crypt 
atrophy 
Hyperplasia Dysplasia 
PCS 1 0 0 0 0 0 0 
PCS 2 0 0 0 0 0 0 
PCS 3 0 0 0 0 0 0 
PCH 1 0 0 0 0 0 0 
PCH 2 0.5 0 0 0 0 0 
PCH 3 0 0 0 0 0 0 
ACH 4 0 0 0 0 0 0 
ACH 5 0 0 0 0 0 0 
ACH 6 0 0 0 0 0 0 
ACS 1  0.5 0 0 0 0 0 
ACS 2 0 0 0 0 0 0 
ACS 3 0.5 0 0 0 0.5 0 
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